Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Johnson & Johnson Could Tap The Huge Diabetes Market With New Drug Approval
Johnson & Johnson Could Tap The Huge Diabetes Market With New Drug Approval
Johnson & Johnson Could Tap The Huge Diabetes Market With New Drug Approval
Submitted by
admin
on March 8, 2013 - 11:03am
Source:
Forbes
News Tags:
JNJ
diabetes
canagliflozin
Headline:
Johnson & Johnson Could Tap The Huge Diabetes Market With New Drug Approval
Do Not Allow Advertisers to Use My Personal information
